SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

60 Degrees Pharmaceuticals Reports PCR-Negative Outcomes in Five Patients

The company said all five completed patients in its expanded access study showed clinical improvement and tested negative for Babesia by conventional PCR; four of five were NAT-negative after treatment. It may pursue accelerated approval using NAT nonreactivity as a surrogate.

SXTP

Related stories